{Reference Type}: Journal Article
{Title}: SNAP: Supportive non-invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team.
{Author}: Cohen RT;Burrowes SAB;Williams CJ;Neri CM;Klings ES;Jones KC;Walkey AJ;Drainoni ML;
{Journal}: Pediatr Blood Cancer
{Volume}: 71
{Issue}: 9
{Year}: 2024 Sep 19
{Factor}: 3.838
{DOI}: 10.1002/pbc.31142
{Abstract}: <B>BACKGROUND: </B>Acute chest syndrome (ACS) often develops during hospitalizations for sickle cell disease (SCD) vaso-occlusive episodes and may be triggered by a combination of chest wall splinting, opioid use, hypoventilation, and atelectasis. In 2017, Boston Medical Center's general pediatric inpatient unit instituted the novel use of bi-level positive airway pressure (BiPAP) as "supportive non-invasive ventilation for ACS prevention" (SNAP) to prevent ACS and respiratory decompensation.<BR><B>OBJECTIVE: </B>The goals of this qualitative study were to identify perceived benefits, harms, facilitators, and barriers to use of SNAP.<BR><B>METHODS: </B>We conducted semi-structured key informant interviews at three sites with different levels of SNAP implementation (Site 1: extensive implementation; Site 2: limited implementation; Site 3: not yet implemented) regarding experiences with and/or perceptions of SNAP. Interviews and coding were guided by the Promoting Action on Research Implementation in Health Services (PARiHS) framework.<BR><B>RESULTS: </B>Thirty-four participants (physicians, nurses, respiratory therapists, child life specialists, psychologists, youth with SCD, and parents) completed interviews. Major themes included: (i) participants perceive BiPAP as effective at preventing ACS, and for those with medically stable ACS, for preventing respiratory decompensation. (ii) BiPAP use is appropriate on the general pediatric inpatient unit for medically stable patients with SCD. (iii) Improving the patient experience is the most important factor to optimize acceptance of BiPAP by patients and families.<BR><B>UNASSIGNED: </B>SNAP is perceived as effective and appropriate for hospitalized pediatric patients with SCD. Improving the patient experience is the biggest challenge. These data will inform a future protocol for a multicenter hybrid effectiveness/implementation trial of SNAP.